éå»1ã¶æéã«Zevra Therapeutics Incã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã9åã«åºã¥ãããŒã¿ã
仿ãZVRAã¯6ä»¶ã®ãè²·ããã0ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããZVRAã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯25.250ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q2ã«çºè¡šãããEPS 0.142ã«ç¶ããZVRAã®FY2026Q3ã®EPSã¯0.157ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD 0.14 ã§ããããZevra Therapeutics IncZVRA ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD 0.65 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD 0.16 ãšäºæ³ãããŸãã